TODAY LETTER DATED

Similar documents
LETTERS FOR ISSUE ON

LETTERS FOR ISSUE ON

THE CORPORATE REPUTATION OF PHARMA THE PATIENT PERSPECTIVE IN 2015 (EASTERN-EUROPE EDITION)

Desire to Work Together

Method of Declaration. Hospitality/Interest/Sponsorship

Emcure Pharmaceuticals Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Participating Indian Companies 1 5M Biotech India 2 Aarti Drugs Ltd. 3 Aarti Industries Limited 4 Aastrid International Pvt. Ltd 5 Aastrid Life

GLOBAL MARKETS AND TECHNOLOGIES FOR ADVANCED DRUG DELIVERY SYSTEMS

TRADE MARKS REGISTRY AHMEDABAD

Corporate Compliance & Transparency

LIGHTHOUSE. The Science of Pharmaceutical Manufacturing

DCRI COMMERCIAL RELATIONSHIPS TRACKING FORM

DCRI COMMERCIAL RELATIONSHIPS TRACKING FORM

Please complete the applicable rows in the following table. Monetary amounts are on an annual basis.

The Role of Patients in Transitions of Care

2017 IPCC Attendee List

Day Hrs Inaugural Session

State of Licensing 2011 Update

(3) Educational Activities or Lectures for this Company Generates Revenue for Duke $5K $25K >$25K

Life Sciences CONFERENCE SERIES. Business Information in a Global Context LIFE SCIENCES IP PORTFOLIO. Business Development Pack

Half-Day Seminar on. Life Sciences Patent Protection in US and India

Please complete the applicable rows in the following table. Monetary amounts are on an annual basis.

ASMI Committee of Management

DCRI COMMERCIAL RELATIONSHIPS TRACKING FORM

WOLPERT ASSOCIATES, INC. Strategic Advisory Services Firm Overview

MARKUSH FOR PATENT ANALYSIS. Steve Hajkowski ChemAxon UGM Budapest 2013

Early Valuation. Company Portfolio

Aqua Pharmaceuticals, LLC

DCRI COMMERCIAL RELATIONSHIPS TRACKING FORM

The 2011 EU industrial R&D investment SCOREBOARD

Associate Director. Biomarker Operations Lead. Business Development & Strategic Alliances. Business Development Executive

Intellectual Property for Industry and Academia Professionals: Training the Trainers

DCRI COMMERCIAL RELATIONSHIPS TRACKING FORM

A Innovative International Limited

Innovation and the Changing Practice of Medicine

TRADE MARKS REGISTRY AHMEDABAD

Management Team. Bruce C. Cozadd Chairman and Chief Executive Officer

SUMMARY OF PROFESSIONAL EXPERIENCE (Nadeem Hussain Alamgir)

Notice for Placement

People. Move PHARMA COMPANIES. on the. Abbott Nutrition International. AstraZeneca. Axcan Pharma. Berlex. Bristol-Myers Squibb

IndiaNivesh Securities Private Limited STOCK HOLDING DISCLOSURE LIST AS ON MAY 30, 2015

D. P. AHUJA & CO. PATENT & TRADEMARK ATTORNEYS

Postgraduate Diploma In Patinformatics (Patent Informatics)

1 Day Seminar on Current Themes in Pharma Patenting - Organized by IPFACE, Venture Center & IP Group, NCL Innovations -

Generics Series: Authorized Generics Analysis Stemming the Generics Tide

PLACEMENT BROCHURE Tapping the.. Untapped reservoir of talent

Other appointments: Chairman of the Advisory Committee of Zentiva Group, Industrial Advisor EQT.

Mixed Signals: Understanding the Outlook for Pharma R&D Spending Through

Biotech Concerto #6 Investment Process December 2008

Using Academic Licensing Agreements to Promote Global Social Responsibility

TUESDAY, 16 FEBRUARY AT THE COURTYARD MARRIOTT, MUMBAI Opp. Big Cinema (Old Sangam Cinema) Andheri Kurla Road, Andheri East HOSTED BY MEDICINMAN

Quarterly Issue Volume 8.3. Dealtracker. Providing M&A and PE market insights. Grant Thornton India LLP. All rights reserved.

Why Value Intellectual Property?

PwC Deals $42B. Global Pharma & Life Sciences Deals Insights Q Update

INDIAN SOCIETY FOR CLINICAL RESEARCH

SZF Associates. SZF is an issues-oriented, evidence-based market research and consulting firm serving the pharmaceutical and biotech industry.

Astellas Announces Full Slate of Independent Director Nominees for Election at OSI Pharmaceuticals 2010 Annual Stockholders Meeting

on the Anne Berberi, formerly Product Manager, Diabetes, at Bristol-Myers Squibb, has been appointed Senior Brand Manager, HCV, at AbbVie.

PROGRAM OBJECTIVES-M.PHARM (PHARMACEUTICAL ANALYSIS)

International Journal of Pharma and Bio Sciences PROCESS ANALYTICAL TECHNOLOGY IMPLEMENTATION- PROGRESSION FOR A PHARMACEUTICAL INDUSTRY ABSTRACT

PROTECT Project. Joanna Groves Chief Executive Officer 27 April 2010 EFPIA Patient Think-Tank Brussels, Belgium

MONTHLY. Volume 2 Issue

VINATI ORGANICS LIMITED

Optics and Spectroscopy for Medical Diagnostics Learn Make Explore! Organized by Venture Center

International Strategy Development Training: a personal strategic development workshop for Life Sciences Executives of SMEs

APPLIED ELECTRONIC CIRCUITS

2018 Building Better Business Connections (3BC) Event Optimizing the Role of Male Champions

INSTITUTE OF MEDICINE COMMITTEE ON THE U.S. COMMITMENT TO GLOBAL HEALTH

Sanofi Announces Changes to Executive Committee Aligned to its Strategic Roadmap 2020

2018 IPCC Attendee List

The 2010 EU industrial R&D investment SCOREBOARD

Launch of new transatlantic specialty pharma company

Chief Trademark Counsel Teva Pharmaceuticals, Inc.

TRADE MARKS REGISTRY AHMEDABAD

Life Sciences Outlook

Life Sciences Outlook. Westchester County 2016

L équipe de direction de Sandoz Canada est diversifiée et détient une vaste expérience dans l industrie pharmaceutique.

The Shape of Things to Come: Massachusetts June 18, 2010 Newton Marriott Hotel

TRADE MARKS REGISTRY AHMEDABAD

Ownership/ Partnership/ Principal. None None None Lantheus Medical Imaging (DSMB) NIH (DSMB)* None None None None None None

Roche's Global IP Strategy 10th. JIPA IP Symposium, Tokyo Dr. Axel Braun F. Hoffmann La Roche Ltd.

Management Oversight and Control: How to Ensure Compliance and Limit Liability

Opportunities for the pharma supply & support network in Emerging Markets

NEW JERSEY INDUSTRY SPOTLIGHT LIFE SCIENCES CUSHMAN & WAKEFIELD RESEARCH

B20 Health Conference Stepping Up Global Health Towards Resilient, Responsible, and Responsive Health Systems

INDIAN INSTITUTE OF MANAGEMENT CALCUTTA WORKING PAPER SERIES. WPS No. 653/ April Trends in Pharmaceutical Patenting in India

Gerresheimer CAPITAL MARKETS DAY 2010

Facets of Technology Transfer: A Perspective of Pharmaceutical Industry

IP for Development Indian Approach

TRADE MARKS REGISTRY AHMEDABAD

Jagadguru Sri Shivarathreeshwara University (Deemed University) Accredited A Grade by NAAC ONE DAY SEMINAR

Conferences. March 17-18, th National Conference And Technology Exhibition on

Digital Medical Device Innovation: A Prescription for Business and IT Success

Newsletter on Indian Healthcare Industry

Life Sciences Outlook. New York City 2016

Healthcare and Life Sciences Group MERGERS & ACQUISITIONS

Accelerating Pharmaceutical Growth through Open Innovation and Global Collaborations

G:\# 2010\Presse\Unternehmensprofile\Englisch\BINDER_Company_Profile_KBA_2010.doc

Purvi B. Maniar Member of the Firm

India's potential as a global biopharma

Transcription:

TODAY LETTER DATED 05.07.2018 BE NOC FOR EXPORT S. NO. NAME OF THE COMPANY REF. NO. TYPE OF LETTER 1. M/S. CLIANTHA RESEARCH LTD., AHMEDABAD-380054 23483 CLARIFICATION LETTER 2. M/S. EMCURE LIMITED, PUNE- 411026 3. M/S. EMCURE LIMITED, PUNE- 411026 4. M/S. GLENMARK LTD., MAHARASHTRA-400026 5. M/S. SUN PHARMACEUTICAL INDUSTRIES LIMITED, VADODARA-390012 20957 TEST LICENCE 19663 AMENDMENT LETTER 21170 AMENDMENT LETTER 22646 APPROVAL LETTER NEW DRUG S.NO. NAME OF APPLICANT DIARY NO. TYPE OF LETTER 1.ICMR NIRT, CHENNAI - SEC MEETING NOTICE (ANTIMICROBIAL & ANTIVIRAL) ON 10.07.2017 2.M/S. DR. CHANCHAL KUMAR, SENIOR RESIDENT, DEPARTMENT OF NEONATOLOGY, JIPMER, PUDUCHERRY 3.M/S. SUN PHARMA LABORATORIES LTD. (SPLL) - SEC MEETING NOTICE (NEUROLOGY & PSYCHIATRY) ON 11.07.2017 - SEC MEETING NOTICE (NEUROLOGY & PSYCHIATRY) ON 11.07.2017 4.M/S. ALKEM - SEC MEETING NOTICE (ENDOCRINOLOGY & METABOLISM) ON 17.07.2017 5.M/S. GLENMARK - SEC MEETING NOTICE (ENDOCRINOLOGY & METABOLISM) ON 17.07.2017 6.M/S. HETERO - SEC MEETING NOTICE 7.M/S. BOEHRINGER INGELHEIM INDIA PVT LTD - SEC MEETING NOTICE 8.M/S. A. MENARINI INDIA PVT LTD - SEC MEETING NOTICE 9.M/S. G. S. PHARMABUTOR PVT LTD - SEC MEETING NOTICE 10M/S. G. S. PHARMABUTOR PVT LTD - SEC MEETING NOTICE (REPRODUCTIVE & UROLOGY) ON 20.07.2017 (2)

11M/S. AUROBINDO PHARMA LTD - LETTER 12M/S. TORRENT LTD. 21943 QUERY LETTER 13HELIXOR HEILMITTEL PVT LTD - LETTER 14M/S. PHARMAZZ INDIA PVT LTD 22882 QUERY LETTER 15M/S. MSN LAB PVT LTD - QUERY LETTER 16M/S. SANOFI-SYNTHELABO (I) PVT LTD - LETTER 17M/S. BAYER PVT LTD - QUERY LETTER SUBSEQUENT NEW DRUG S. NO. NAME OF THE FIRM REFERENCE NO. FTS NO. TYPE OF LETTER 1. M/S ICMR 10160 - SEC INVITATION LETTER FOR UPCOMING SEC ANTIMICROBIAL & ANTIVIRAL ON 10.07.2018 2. M/S ZIM LABORATORIES 13343 19517 SEC INVITATION LETTER FOR 3. M/S ZIM LABORATORIES 16963 24425 SEC INVITATION LETTER FOR 4. M/S INTAS 19428 921726 SEC INVITATION LETTER FOR 5. M/S AJANTA PHARMA - - SEC INVITATION LETTER FOR UPCOMING SEC ANALGESIC & RHEUMATOLOGY ON 12.07.2018 6. M/S THEMIS MEDICARE 18375 915407 SEC INVITATION LETTER FOR UPCOMING SEC ANALGESIC & RHEUMATOLOGY ON 12.07.2018 7. M/S INTAS 21239 939698 SEC INVITATION LETTER FOR UPCOMING SEC ENDOCRINOLOGY & METABOLISM ON 17.07.2018 8. M/S ASTRAZENCA 15038 21908 SEC INVITATION LETTER FOR 9. M/S INTAS 18494 915328 SEC INVITATION LETTER FOR 10. M/S BMS 18646 915559 SEC INVITATION LETTER FOR

11. M/S VIRCHOW 20078 927136 SEC INVITATION LETTER FOR 12. M/S UNIQUE 20615 931630 SEC INVITATION LETTER FOR UPCOMING SEC PULMONARY ON 19.07.2018 13. M/S GURMAIL BROTHER 20067 927090 SEC INVITATION LETTER FOR UPCOMING SEC REPRODUCTIVE & UROLOGY ON 20.07.2018 14. M/S SYNOKEM 19016 917527 SEC INVITATION LETTER FOR UPCOMING SEC REPRODUCTIVE & UROLOGY ON 20.07.2018 15. M/S SYNOKEM 20032 927916 DEFICIENCY LETTER 16. M/S RUSAN PHARMA 2492 3853 DEFICIENCY LETTER (2) 17. M/S CADILA HEALTHCARE 12046 - DEFICIENCY LETTER 18. M/S LAURUS LABS 22232 947249 DEFICIENCY LETTER 19. M/S INTAS 15912 23288 DEFICIENCY LETTER MEDICAL DEVICE DIVISION S.NO. COMPANY NAME DIARY NO STATUS 1. M/S. CENTRAL GLASS & CERAMIC RESEARCH INSTITUTE, (CSIR) 5992 LETTER 2. M/S. MERIL LIFE SCIENCES PVT. LTD., 214 LETTER 3. M/S. MERIL LIFE SCIENCES PVT. LTD., 22301 LETTER 4. M/S. RECKITT BENCKISER (INDIA) PVT. LTD., 19041 LETTER 5. M/S. STERIMED SURGICALS (I) PVT. LTD., 23044 LETTER 6. M/S. REGENCY LIFE SCIENCES INDIA PVT. LTD., 21891 LETTER

7. M/S. NIRAMAI HEALTH ANALYTIX PVT. LTD., 21237 LETTER DIAGNOSTIC DIVISION S.NO. COMPANY NAME DIARY NO STATUS 1. M/S. ADT, INDIA PVT. LTD., 21954 LETTER 2. M/S. ANNWESHAN SCI TECH PVT. LTD., 949612 LETTER 3. M/S. SYNERGY MEDICAL SYSTEMS LLP., 22240 LETTER BIOLOGICAL DIVISION S. NO. NAME OF FIRM REFERENCE NO. TYPE OF LETTER 1 M/S NOVO NORDISK INDIA 9215 ACKNOWLEDGE LETTER 2 M/S BAYER 20351 ACKNOWLEDGE LETTER 3 M/S ROCHE PRODUCTS INDIA 7844 ACKNOWLEDGE LETTER 4 M/S HETERO BIOPHARMA LTD 15995 ACKNOWLEDGE LETTER 5 M/S SANDOZ PVT LTD 15013 ACKNOWLEDGE LETTER 6 M/S MSD 16664 CDL & CLARIFICATION LETTER 7 M/S PANACEA BIOTECH LTD 17809 CDL LETTER 8 M/S SERUM INSTITUTE OF INDIA 9 M/S JOHNSON & JOHNSON 10 M/S BHARAT BIOTECH INTERNATIONAL LTD 11 M/S MERCK SPECIALTIES PVT, LTD 19973 CLARIFICATION LETTER 20029 CLARIFICATION LETTER 20216 CLARIFICATION LETTER 19396 AMENDMENT & CLARIFICATION LETTER

FDC DIVISION S.NO. NAME OF COMPANY DIARY NO. DOCUMENT 1. M/S. ERIS LIFE SCIENCES 9202/NIL LETTER/SEC LETTER 2. M/S. SIGMA-TAU INDIA NIL SEC MEETING